直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

European IP Blog

Delayed Start Date for the Unified Patent Court and the Unitary Patent

December 7, 2022

Authored and Edited by Dr. Antje Brambrink; Nicholas Russell Philip Fox

The start of the Unified Patent Court (UPC) has been postponed for two months. Originally slated to open 1 April 2023, the UPC will now commence on 1 June 2023. This delay also applies to the "sunrise" period when patentees can start opting rights out from the jurisdiction of the court and the date when Unitary Patents will start being granted. 

The UPC court system is supposed to be fully digital. One of the cornerstones of the court is therefore its Case Management System (CMS) – the digital platform which enables users to file documents with the court, including filing opt-out declarations for European bundle patents which can start to be filed during a “sunrise period” three months in advance of the court’s official launch date. Filing opt-outs will be an early test for the CMS, and it is of utmost importance that anyone who wants to do so is able to access the CMS as soon as the sunrise period starts.

There has been much discussion on the technical functionality of the CMS in recent weeks, in particular in relation to the difficulties users are having obtaining the technical equipment required to access the system. Access to the CMS is via smart cards issued through EU Trust Service Providers. The UPC website provides a link to a list of organizations issuing the required smart cards. However, it seems that there have been problems with providers issuing the necessary technical equipment for accessing the CMS. In view of these problems, the launch of the UPC has been delayed in order to give users more time to obtain the required access tools.

The UPC sunrise period is therefore now scheduled to commence on 1 March 2023 instead of 1 January 2023 as originally intended. As noted earlier, the court is now expected to open its doors for business on 1 June 2023.

In a statement the UPC confirmed that all other aspects of the preparatory work (e.g., appointment and training of the UPC Judges, etc.) were all proceeding to schedule, and would not cause the opening of the court to be delayed. Clearly the court is of the view that the two month delay will be sufficient for the remaining issues with the CMS to be resolved and is optimistic that it will not be necessary to put the start date for the new court back any further.

Although further delays in the opening of the UPC are unwelcome, evidently the court was of the view that announcing a two month delay was essential to ensure that the CMS is fully accessible on day one of the sunrise period. On a positive note, the delay does provide patent right holders and potential litigants a further two months to prepare for the opening of the new court.

For more information, visit our Insights:

Unified Patent Court FAQ

Unitary Patent FAQ

Strategic Considerations for Opting in or out of the Unified Patent Court

Tags

Unified Patent Court (UPC)

Related Practices

Global IP Enforcement, Litigation, and Trials

Unitary Patent System (UPS) and the Unified Patent Court (UPC)

Related Offices

London

Munich

Contacts

Dr. Antje Brambrink
Partner
Munich
+49 89 83931 1239
Email

Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

Conference

BIA Start-up Festival

May 21, 2026

London

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Virtual Seminar

Patent "Basics" Seminar

May 19, 2026

Virtual

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP